Patent details

Basic Information

Publication number:

EP3491025

PCT Application Number:

US2017044765

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP178354361

PCT Publication Number:

WO2018023136

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

FCRN ANTIBODIES AND METHODS OF USE THEREOF

French Title of Invention:

ANTICORPS FCRN ET LEURS PROCÉDÉS D'UTILISATION

German Title of Invention:

FCRN-ANTIKÖRPER UND VERFAHREN ZUR VERWENDUNG DAVON

SPC Number:

Dates

Filing date:

31/07/2017

Grant date:

18/10/2023

EP Publication Date:

05/06/2019

PCT Publication Date:

01/02/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/10/2023

EP B1 Publication Date:

18/10/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

31/07/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/10/2023

 

 

Name:

Momenta Pharmaceuticals, Inc.

Address:

1125 Trenton-Harbourton Road, Titusville, NJ 08560, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

23/10/2023

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

WASHBURN, Nathaniel

Address:

United States (US)

2

Name:

KEHRY, Marilyn

Address:

United States (US)

3

Name:

MEADOR, James, III

Address:

United States (US)

4

Name:

HILLSON, Jan

Address:

United States (US)

5

Name:

MANNING, Anthony

Address:

United States (US)

6

Name:

LING, Leona, E.

Address:

United States (US)

7

Name:

KING, David, J.

Address:

United States (US)

8

Name:

ROY, Sucharita

Address:

United States (US)

Priority

1

Priority Number:

201662368803 P

Priority Date:

29/07/2016

Priority Country:

United States (US)

2

Priority Number:

201662368770 P

Priority Date:

29/07/2016

Priority Country:

United States (US)

Classification

IPC classification:

C07K 16/28; G01N 33/68; A61P 37/00; A61P 37/02;

Publication

European Patent Bulletin

Issue number:

202342

Publication date:

18/10/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

31/07/2026

Annual Fee Number:

10

Annual Fee Amount:

131 Euro

Expected Payer:

Last Annual Fee Payment Date:

14/07/2025

Last Annual Fee Paid Number:

9

Last Annual Fee Paid Amount:

115 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
23/10/2023	Power Of Attorney	1
23/10/2023	Outgoing Correspondence	1